Tofacitinib
NDC 60505-6263, tofacitinib, tablet, film coated, from Apotex Corp..
- Product NDC
- 60505-6263
- Status
- Listed
- Labeler
- Apotex Corp.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218096
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6263 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOFACITINIB5 mg/1
Pharmacologic classes
Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60505-6263-5 | 60505626305 | 500 TABLET, FILM COATED in 1 BOTTLE (60505-6263-5) |
| 60505-6263-6 | 60505626306 | 60 TABLET, FILM COATED in 1 BOTTLE (60505-6263-6) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7d4f5cfa-35a8-1458-a609-f6b417946abbNADAC price for package 60505626306
GET /v1/drugs/nadac/60505626306
Use it
Look up 60505-6263 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6263 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60505-6263. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.